Bioactive Materials

Bioactive Materials Market Outlook

The global bioactive materials market is projected to reach approximately USD 121 billion by 2035, growing at a robust CAGR of around 8.2% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing demand for advanced biomaterials in medical applications, particularly in orthopedics and dental sectors, alongside a rising incidence of chronic diseases that require surgical intervention. Furthermore, advancements in technology for developing innovative bioactive materials that promote tissue regeneration and healing are gaining momentum. The increasing geriatric population and the growing trend toward minimally invasive surgeries are also contributing to the market's expansion, making bioactive materials a focal point for research and development in the biomedical field.

Growth Factor of the Market

Several factors are contributing to the growth of the bioactive materials market, the foremost being the rising need for effective medical solutions that enhance recovery and healing. The increasing prevalence of age-related ailments, such as osteoporosis and dental issues, is driving the demand for bioactive materials in orthopedic and dental applications. Moreover, the continuous advancements in biomedical technologies, including 3D printing and bioengineering, are allowing for the creation of more sophisticated materials that exhibit enhanced biocompatibility and functionality. The growth of healthcare infrastructure, particularly in emerging economies, is also fueling demand for innovative medical devices, further propelling the need for bioactive materials. Additionally, ongoing research and development initiatives aimed at creating next-generation bioactive materials promise to expand the market significantly. Regulatory support and funding for biomedical research play crucial roles in facilitating innovations in this sector, thereby bolstering market growth.

Key Highlights of the Market

• The bioactive materials market is expected to witness a CAGR of approximately 8.2% from 2025 to 2035.
• Orthopedic applications dominate the market, driven by the rising number of orthopedic surgeries worldwide.
• North America holds a significant share of the market, attributed to advanced healthcare infrastructure.
• Bioactive Glasses are projected to lead the product type segment due to their excellent bioactivity and biocompatibility.
• Increased investment in research and development is paving the way for innovative bioactive materials and applications.

By Product Type

Bioactive Glasses:

Bioactive glasses are among the most promising biomaterials used in various medical applications due to their excellent bioactivity and ability to form strong bonds with bone. They are primarily utilized in orthopedic and dental applications, where they successfully promote osteoconduction and osteointegration. The SiO2-based glasses can release ions that promote bone regeneration, making them suitable for bone repair and replacement procedures. As the technology continues to advance, the formulation of new bioactive glass compositions is expanding to enhance their mechanical properties and bioactivity, leading to their increasing adoption in clinical settings.

Bioactive Ceramics:

Bioactive ceramics possess high biocompatibility and are widely used in the medical field for bone grafting and dental implants. They encourage the growth of new bone through ionic dissolution, which releases beneficial ions into the surrounding environment. Hydroxyapatite, a commonly used bioactive ceramic, mimics the mineral component of bone, making it highly effective for applications requiring bone integration. The market for bioactive ceramics is anticipated to grow, driven by innovations in material science that enhance their properties, such as strength and degradation rates, making them suitable for a broader range of applications.

Bioactive Polymers:

Bioactive polymers are gaining traction in the bioactive materials market due to their versatility and ability to provide tailored properties for specific medical applications. These polymers can be engineered to exhibit desirable characteristics such as biodegradability, elasticity, and bioactivity, making them ideal for various applications, including drug delivery systems and tissue engineering scaffolds. The growing focus on regenerative medicine is propelling the demand for bioactive polymers, as they can support cell adhesion and growth, facilitating tissue regeneration. Their potential for customization is creating opportunities for innovation and market expansion.

Bioactive Composites:

Bioactive composites combine the benefits of both organic and inorganic materials, resulting in products that possess enhanced mechanical properties and bioactivity. These composites are designed to mimic the structure of natural bone, optimizing their use in orthopedic and dental applications. The demand for bioactive composites is driven by their superior performance in load-bearing applications and their ability to promote cellular infiltration and integration. As research continues to explore novel composite formulations, the market for these materials is expected to expand significantly, driven by their applicability in various surgical scenarios.

Bioactive Metals:

Bioactive metals, such as magnesium and titanium alloys, are increasingly being recognized for their potential in biomedical applications due to their mechanical strength and favorable biological interactions. These materials can promote bone growth and integration, making them suitable for load-bearing implants. The development of bioactive metals that can degrade in the body, providing temporary support until natural healing occurs, is a significant area of research. This innovation is expected to propel the market forward as it addresses the limitations of traditional permanent implants. The growing demand for bioactive metals is indicative of the evolving landscape of medical implants and surgical solutions.

By Application

Orthopedics:

The orthopedic application segment is a significant driver of the bioactive materials market due to the increasing prevalence of musculoskeletal disorders and the aging population. Bioactive materials used in orthopedics, such as bioactive glasses and ceramics, are crucial for bone repair and regeneration. They facilitate the healing process by enhancing osteoconductivity and promoting new bone formation. This demand is further supported by the rise in orthopedic surgeries, including joint replacements and fracture repairs, where bioactive materials offer superior performance compared to conventional materials. As technology progresses, the introduction of novel implants designed to be more effective in body integration will likely enhance growth in this segment.

Dental:

The dental application of bioactive materials is characterized by their use in restorative procedures, implants, and orthodontics. Bioactive glass and composite materials are utilized to promote dental tissue regeneration and enhance the bonding of restorative materials to tooth structures. With the rising awareness of oral health and advancements in dental technology, there is an increasing demand for bioactive materials that improve outcomes in dental procedures. The growth of cosmetic dentistry and a greater emphasis on aesthetics in dental practice are also driving the adoption of bioactive materials, facilitating the development of innovative solutions in this domain.

Tissue Engineering:

Tissue engineering is an emerging application area for bioactive materials, focused on creating functional tissues to replace damaged or diseased ones. Bioactive scaffolds made from polymers, ceramics, or composites can provide the necessary support for cell attachment, growth, and differentiation. As regenerative medicine continues to evolve, the demand for high-performance bioactive materials in tissue engineering applications is expected to surge. Research in this field is actively exploring new methodologies for enhancing the properties of bioactive materials, aiming to achieve better integration and functionality in engineered tissues.

Drug Delivery:

The drug delivery segment is increasingly recognizing the potential of bioactive materials in developing advanced delivery systems that enhance the efficacy of therapeutic agents. Bioactive polymers, in particular, are being engineered to achieve controlled release profiles, improving the bioavailability of various drugs. These materials can help target specific tissues, minimizing side effects while maximizing treatment outcomes. The growth of personalized medicine and the need for innovative delivery mechanisms is driving interest in bioactive materials, as they can be tailored to fulfill specific therapeutic requirements effectively. As research in this area continues to expand, the market for bioactive materials in drug delivery is expected to grow significantly.

Other Medical Applications:

Beyond orthopedics, dental, and tissue engineering, bioactive materials find applications in various other medical fields, including cardiovascular, ophthalmic, and wound healing therapies. These materials are being studied for their potential to interact positively with biological systems, promoting healing and minimizing rejection. For instance, bioactive materials can be used in vascular grafts to improve the integration of implants with natural tissue. As the understanding of bioactive materials continues to grow, their versatility opens up opportunities for innovative applications across diverse medical sectors, further driving market expansion.

By User

Hospitals:

Hospitals are a primary end-user of bioactive materials, where these products are integral to surgical procedures and patient care. The increasing number of surgical interventions and the growing emphasis on minimally invasive techniques are driving the demand for bioactive materials within hospital settings. Hospitals often leverage advanced bioactive materials for both acute care and routine procedures, using them in orthopedic surgeries, dental procedures, and trauma care. The ongoing advancements in medical technology and increasing healthcare expenditures are expected to boost the demand for bioactive materials in hospitals, further enhancing patient outcomes.

Clinics:

Clinics, particularly specialized outpatient facilities, are increasingly adopting bioactive materials for various medical applications. These settings focus on providing targeted care, making use of bioactive materials in non-invasive procedures, such as dental restorations and minor surgical interventions. The growing trend of aesthetic and cosmetic procedures in clinics is also contributing to the demand for innovative bioactive materials, as practitioners seek solutions that enhance patient satisfaction. As the healthcare landscape shifts towards outpatient care, the role of bioactive materials in clinical settings is anticipated to expand significantly.

Research Institutes:

Research institutes are pivotal in advancing the bioactive materials market through innovation and development. These institutions engage in extensive research programs focused on developing new biomaterials and exploring their applications in medicine. The collaboration between research institutes and commercial entities is fostering the creation of innovative bioactive products, enhancing their scope in medical applications. Ongoing research is crucial for understanding the interactions between bioactive materials and biological environments, which is essential for improving their efficacy and safety. As funding for biomedical research increases, the contributions of research institutes to the bioactive materials market are expected to grow, driving innovation and market growth.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) represent a critical segment of the bioactive materials market, offering outpatient surgical procedures that require advanced materials for optimal patient outcomes. The shift towards outpatient surgeries, where patients can receive care and return home on the same day, is driving the adoption of bioactive materials in these centers. ASCs often utilize bioactive materials for procedures such as joint injections and minor orthopedic surgeries, where the efficacy of materials plays a crucial role in recovery. The increasing focus on cost-effective healthcare solutions is further promoting the use of bioactive materials in ASCs, enhancing their operational efficiencies and patient satisfaction.

Others:

The "Others" category encompasses various players involved in the bioactive materials market, including pharmacies, rehabilitation centers, and home healthcare providers. Each of these entities contributes to the growing demand for bioactive materials by utilizing them in patient-centered care solutions. For instance, rehabilitation centers may use bioactive materials in therapeutic devices aimed at enhancing recovery post-surgery. Pharmacies play a role in distributing bioactive materials in the form of medical devices and implants, ensuring comprehensive access to innovative healthcare solutions. The diverse usage of bioactive materials across different sectors underscores the importance of this market segment in driving overall industry growth.

By Material Type

Hydroxyapatite:

Hydroxyapatite is a naturally occurring mineral form of calcium apatite and is widely used in medical applications due to its excellent biocompatibility and bioactivity. It mimics the mineral component of bone, making it suitable for orthopedic and dental implants. Hydroxyapatite can also be used as a coating material for metal implants to enhance their integration with surrounding bone tissue. The growing demand for bone graft substitutes and the increasing number of orthopedic surgeries are expected to drive the market for hydroxyapatite significantly. Ongoing research is focused on enhancing its properties, such as its mechanical strength and degradation rates, to broaden its application scope.

Bioglass:

Bioglass is a type of bioactive glass that has gained prominence in the bioactive materials market due to its remarkable bioactivity and ability to form a strong bond with surrounding tissues. It is primarily used in applications such as bone repair and dental restorations. Bioglass has the unique advantage of being able to stimulate cellular activity and promote tissue regeneration, making it ideal for use in various medical applications. The versatility of bioglass formulations enables customization for specific applications, further fueling its adoption in the market. Research into new bioglass compositions is expected to enhance its mechanical and biological properties, driving its growth in the coming years.

Calcium Phosphate:

Calcium phosphate is a prominent class of bioceramics widely used in the bioactive materials market due to its excellent biocompatibility and osteoconductive properties. It closely resembles the mineral composition of bone, making it an ideal choice for bone grafts and implants. Calcium phosphate materials facilitate natural bone regeneration by providing a scaffold for cell attachment and growth. The increasing incidence of bone-related disorders and the demand for effective bone repair solutions are propelling the growth of calcium phosphate in the market. Moreover, advancements in calcium phosphate formulations are enabling better control over their physical and chemical properties, further broadening their applications.

Silicate-based:

Silicate-based bioactive materials are emerging as a significant category within the bioactive materials market due to their favorable bioactive properties and ability to promote bone regeneration. These materials are being studied for their potential applications in bone repair, dental implants, and tissue engineering. Silicate ions released from these materials can enhance the biological responses of surrounding tissues, offering promising results in achieving better integration and healing outcomes. As research continues to explore the beneficial effects of silicate ions, the market for silicate-based bioactive materials is expected to grow significantly, driven by their potential applications in various medical fields.

Others:

The "Others" category includes a variety of bioactive materials that do not fit into the primary classifications but still hold significant potential in the market. This may encompass novel materials being developed through advanced research and innovative technologies, such as organic-inorganic composites and new metallic bioactive materials. These emerging materials are characterized by their unique properties that can enhance performance in medical applications. The ongoing research into new formulations and composites is expected to drive the growth of this segment, as specialized applications in regenerative medicine, drug delivery, and tailored implants gain traction in the bioactive materials market.

By Region

The bioactive materials market is experiencing regional growth driven by varying healthcare advancements and market demands across different areas. North America currently holds a dominant share of the market, with a value exceeding USD 45 billion in 2025. The region's advanced healthcare infrastructure and significant investment in research and development are key factors contributing to this growth. Furthermore, the increasing prevalence of chronic diseases and the rising demand for orthopedic and dental procedures are propelling the adoption of bioactive materials. The CAGR for North America is projected at around 6.9%, highlighting the continued growth potential in this region.

Europe follows closely, with a market size anticipated to reach approximately USD 35 billion by 2025. The growing aging population in countries such as Germany, France, and the UK is driving the demand for bioactive materials, particularly in orthopedic and dental applications. Additionally, the region's emphasis on technological advancements and regulatory support for innovative medical solutions is further fostering market growth. The Asia Pacific region is also witnessing significant growth, projected to reach around USD 25 billion by 2025, with a CAGR of 9.1%. Rapid urbanization, increasing healthcare expenditures, and growing awareness of advanced medical technologies in countries like China and India are boosting demand in this region.

Opportunities

The bioactive materials market presents numerous opportunities for growth, particularly as technological advancements continue to evolve. One of the most significant opportunities lies in the development of personalized medicine, where bioactive materials can be tailored to suit the unique needs of individual patients. This customization can lead to improved clinical outcomes, as materials can be designed to interact more effectively with specific biological environments. Furthermore, advancements in 3D printing technology offer the potential to manufacture bioactive materials with complex geometries, enhancing their application in tissue engineering and regenerative medicine. As research institutions and companies collaborate to explore these innovations, the market for bioactive materials is poised to benefit from new product developments and expanded applications.

Additionally, emerging markets in Asia Pacific and Latin America present significant growth opportunities for bioactive materials. The increasing healthcare spending in these regions, coupled with the rising prevalence of lifestyle-related diseases, is driving demand for advanced medical solutions. The establishment of robust healthcare infrastructures and improved access to medical care is likely to foster the adoption of bioactive materials in various applications. Companies that strategically position themselves to capitalize on these opportunities, through partnerships and collaborations, are expected to thrive in the expanding global bioactive materials market.

Threats

While the bioactive materials market is poised for growth, it is not without its threats. One of the primary challenges is the stringent regulatory landscape that governs the approval and commercialization of new biomaterials. Regulatory bodies require extensive testing and validation of bioactive materials to ensure safety and efficacy, which can lead to delayed product launches and increased costs for manufacturers. Furthermore, the fast-paced nature of technological advancements means that companies must continually invest in research and development to stay competitive, which can strain financial resources. The potential for adverse reactions or complications from bioactive materials, although rare, can also pose risks to market growth, as negative clinical outcomes may affect the public's perception and acceptance of these materials.

Another significant threat to the bioactive materials market is the availability of alternative materials. Traditional materials, such as metals and polymers, continue to dominate certain applications due to their established performance and reliability. The competition from these materials poses a challenge for bioactive materials, particularly in cost-sensitive markets where price may outweigh performance benefits. Companies must not only highlight the advantages of bioactive materials but also effectively communicate their value proposition to healthcare providers and patients to overcome these challenges and maintain market relevance.

Competitor Outlook

• DePuy Synthes
• Zimmer Biomet
• Medtronic
• Stryker Corporation
• Globus Medical
• Smith & Nephew
• Heraeus Medical
• Osstem Implant
• Cam Bioceramics
• Biomet 3i
• Geistlich Pharma AG
• CoorsTek
• Ivoclar Vivadent
• Covalon Technologies
• 3M Company

The competitive landscape of the bioactive materials market is characterized by a blend of established players and new entrants striving to capitalize on the growing demand for innovative biomaterials. Major companies, such as DePuy Synthes and Zimmer Biomet, are leveraging their extensive research and development capabilities to introduce advanced bioactive materials for various medical applications. These companies are investing heavily in developing proprietary technologies and products that enhance the healing process and improve patient outcomes. Furthermore, collaborations with research institutions and universities are fostering innovation, allowing these companies to stay ahead of the competition while meeting stringent regulatory requirements.

Medtronic and Stryker Corporation are also prominent players in the bioactive materials market. Medtronic focuses on creating innovative medical devices that incorporate bioactive materials, enabling better integration within the body and promoting tissue regeneration. Stryker, on the other hand, is continuously expanding its product portfolio in orthopedics, emphasizing the use of bioactive materials in implants and surgical solutions. Their strategic acquisitions and partnerships have bolstered their market position, allowing them to enhance their technological capabilities and drive growth further.

Additionally, companies like Geistlich Pharma AG and Covalon Technologies are gaining recognition for their specialized products. Geistlich Pharma focuses on regenerative dentistry and orthobiologics, producing bioactive materials that facilitate bone and tissue regeneration. Covalon Technologies is known for its advanced wound care products that incorporate bioactive materials, enhancing the healing process for patients with chronic wounds. As the market continues to evolve, these companies are expected to play a crucial role in shaping the future of the bioactive materials landscape by introducing innovative solutions that address emerging healthcare challenges.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 CoorsTek
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Biomet 3i
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 3M Company
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 DePuy Synthes
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Zimmer Biomet
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Globus Medical
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Osstem Implant
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Smith & Nephew
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Cam Bioceramics
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Heraeus Medical
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Ivoclar Vivadent
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Geistlich Pharma AG
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Stryker Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Covalon Technologies
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Bioactive Materials Market, By User
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Research Institutes
    • 6.1.4 Ambulatory Surgical Centers
    • 6.1.5 Others
  • 6.2 Bioactive Materials Market, By Application
    • 6.2.1 Orthopedics
    • 6.2.2 Dental
    • 6.2.3 Tissue Engineering
    • 6.2.4 Drug Delivery
    • 6.2.5 Other Medical Applications
  • 6.3 Bioactive Materials Market, By Product Type
    • 6.3.1 Bioactive Glasses
    • 6.3.2 Bioactive Ceramics
    • 6.3.3 Bioactive Polymers
    • 6.3.4 Bioactive Composites
    • 6.3.5 Bioactive Metals
  • 6.4 Bioactive Materials Market, By Material Type
    • 6.4.1 Hydroxyapatite
    • 6.4.2 Bioglass
    • 6.4.3 Calcium Phosphate
    • 6.4.4 Silicate-based
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Bioactive Materials Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Bioactive Materials market is categorized based on

By Product Type

• Bioactive Glasses
• Bioactive Ceramics
• Bioactive Polymers
• Bioactive Composites
• Bioactive Metals

By Application

• Orthopedics
• Dental
• Tissue Engineering
• Drug Delivery
• Other Medical Applications

By User

• Hospitals
• Clinics
• Research Institutes
• Ambulatory Surgical Centers
• Others

By Material Type

• Hydroxyapatite
• Bioglass
• Calcium Phosphate
• Silicate-based
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• DePuy Synthes
• Zimmer Biomet
• Medtronic
• Stryker Corporation
• Globus Medical
• Smith & Nephew
• Heraeus Medical
• Osstem Implant
• Cam Bioceramics
• Biomet 3i
• Geistlich Pharma AG
• CoorsTek
• Ivoclar Vivadent
• Covalon Technologies
• 3M Company